Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

14%

1 trials in Phase 3/4

Results Transparency

25%

1 of 4 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A

6(85.7%)

Phase 4

1(14.3%)

7Total

N/A(6)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT03727191Not ApplicableCompleted

Coverage of Requirements After Consumption of a Nutritional Formula in Patients With Chewing/Swallowing Problems.

Role: collaborator

NCT01233726Not ApplicableCompleted

Effects of a Complete Diet in Critically Ill Patients With Stress Hyperglycemia

Role: lead

NCT02622880Phase 4Completed

Comparison of Two Immunomodulatory Formulas on the Number of Postoperative Infections in Head & Neck Cancer Patients

Role: collaborator

NCT01247714Not ApplicableUnknown

Clinical Evaluation of a Specific Enteral Diet for Diabetics

Role: lead

NCT01192529Not ApplicableUnknown

Evaluation of a Diet in Patients With Senile Dementia

Role: lead

NCT01249963Not ApplicableUnknown

Enteral Nutrition Product in Mild Acute Pancreatitis

Role: lead

NCT01303289Not ApplicableCompleted

Clinical Evaluation of a Normoproteic Diet

Role: lead

All 7 trials loaded